MERSANA THERAPEUTICS

mersana-therapeutics-logo

Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. It was founded in 2005 and headquartered in Cambridge, Massachusetts.
#SimilarOrganizations #People #Financial #Event #Website #More

MERSANA THERAPEUTICS

Social Links:

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2005-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.mersana.com

Total Employee:
101+

Status:
Active

Contact:
617-498-0020

Email Addresses:
[email protected]

Total Funding:
480.61 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

affimed-logo

Affimed

Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.

akebia-therapeutics-logo

Akebia Therapeutics

Akebia Therapeutics develops treatments for ischemia and vascular diseases.

protagonist-therapeutics-logo

Protagonist Therapeutics

Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.


Current Advisors List

not_available_image

David Colcher Scientific Advisory Board @ Mersana Therapeutics
Advisor

david-parkinson_image

David Parkinson Member of the Scientific Advisory Board @ Mersana Therapeutics
Advisor

christoph-lengauer_image

Christoph Lengauer Scientific Advisory Board @ Mersana Therapeutics
Advisor

david-mott_image

David Mott Executive Chairman @ Mersana Therapeutics
Board_member
2012-07-01

nicholas-bacopoulos_image

Nicholas Bacopoulos Board of Directors @ Mersana Therapeutics
Board_member
2007-01-01

greg-adams_image

Greg Adams Scientific Advisory Board @ Mersana Therapeutics
Advisor

thomas-r-beck_image

Thomas R. Beck Board of Directors @ Mersana Therapeutics
Board_member

sara-nayeem_image

Sara Nayeem Board of Directors @ Mersana Therapeutics
Board_member

Current Employees Featured

david-r-elmaleh_image

David R. Elmaleh
David R. Elmaleh Founder @ Mersana Therapeutics
Founder

timothy-b-lowinger_image

Timothy B. Lowinger
Timothy B. Lowinger Chief Science & Technology Officer @ Mersana Therapeutics
Chief Science & Technology Officer
2019-08-01

karen-hong_image

Karen Hong
Karen Hong Principal, ProQuest Investments @ Mersana Therapeutics
Principal, ProQuest Investments

k-dane-wittrup_image

K. Dane Wittrup
K. Dane Wittrup Member, Scientific Advisory Board @ Mersana Therapeutics
Member, Scientific Advisory Board
2015-05-01

mohan-bala_image

Mohan Bala
Mohan Bala SVP, Strategic Product Planning & Program Leadership @ Mersana Therapeutics
SVP, Strategic Product Planning & Program Leadership
2021-10-01

anna-protopapas_image

ANNA PROTOPAPAS
ANNA PROTOPAPAS President & CEO @ Mersana Therapeutics
President & CEO
2015-03-01

tushar-misra_image

Tushar Misra
Tushar Misra Chief Manufacturing Officer @ Mersana Therapeutics
Chief Manufacturing Officer
2021-08-01

dirk-huebner_image

Dirk Huebner
Dirk Huebner Chief Medical Officer @ Mersana Therapeutics
Chief Medical Officer

brian-deschuytner_image

Brian DeSchuytner
Brian DeSchuytner Chief Financial Officer @ Mersana Therapeutics
Chief Financial Officer
2021-10-01

Founder


david-r-elmaleh_image

David R. Elmaleh

Stock Details


Company's stock symbol is NASDAQ:MRSN

Investors List

bain-capital-life-sciences_image

Bain Capital Life Sciences

Bain Capital Life Sciences investment in Post-IPO Equity - Mersana Therapeutics

consonance-capital-partners_image

Consonance Capital Partners

Consonance Capital Partners investment in Post-IPO Equity - Mersana Therapeutics

avoro-capital-advisors_image

Avoro Capital Advisors

Avoro Capital Advisors investment in Post-IPO Equity - Mersana Therapeutics

arrowpoint-partners_image

ArrowMark Partners

ArrowMark Partners investment in Series C - Mersana Therapeutics

cormorant-asset-management_image

Cormorant Asset Management

Cormorant Asset Management investment in Series C - Mersana Therapeutics

rock-springs-capital_image

Rock Springs Capital

Rock Springs Capital investment in Series C - Mersana Therapeutics

wellington-management_image

Wellington Management

Wellington Management investment in Series C - Mersana Therapeutics

new-enterprise-associates_image

New Enterprise Associates

New Enterprise Associates investment in Series C - Mersana Therapeutics

takeda-pharmaceutical_image

Takeda

Takeda investment in Series C - Mersana Therapeutics

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Series B - Mersana Therapeutics

Official Site Inspections

http://www.mersana.com Semrush global rank: 6.43 M Semrush visits lastest month: 1.02 K

  • Host name: 204.182.199.35.bc.googleusercontent.com
  • IP address: 35.199.182.204
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Mersana Therapeutics" on Search Engine

dfkcompany.com © 2022. All rights reserved